Yousef, R.G.; Elkady, H.; Elkaeed, E.B.; Gobaara, I.M.M.; Al-ghulikah, H.A.; Husein, D.Z.; Ibrahim, I.M.; Metwaly, A.M.; Eissa, I.H.
(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules 2022, 27, 7719.
https://doi.org/10.3390/molecules27227719
AMA Style
Yousef RG, Elkady H, Elkaeed EB, Gobaara IMM, Al-ghulikah HA, Husein DZ, Ibrahim IM, Metwaly AM, Eissa IH.
(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules. 2022; 27(22):7719.
https://doi.org/10.3390/molecules27227719
Chicago/Turabian Style
Yousef, Reda G., Hazem Elkady, Eslam B. Elkaeed, Ibraheem M. M. Gobaara, Hanan A. Al-ghulikah, Dalal Z. Husein, Ibrahim M. Ibrahim, Ahmed M. Metwaly, and Ibrahim H. Eissa.
2022. "(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies" Molecules 27, no. 22: 7719.
https://doi.org/10.3390/molecules27227719
APA Style
Yousef, R. G., Elkady, H., Elkaeed, E. B., Gobaara, I. M. M., Al-ghulikah, H. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H.
(2022). (E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules, 27(22), 7719.
https://doi.org/10.3390/molecules27227719
